AMCA
AMED

Arthur M. Cohen & Associates’s Amedisys AMED Stock Holding History

Arthur M. Cohen & Associates’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,000
Closed -$245K – 137
2021
Q2 		$245K Hold
1,000
– – 0.05% 136
2021
Q1 		$265K Hold
1,000
– – 0.06% 127
2020
Q4 		$293K Buy
1,000
+900
+900% +$231K 0.07% 123
2020
Q3 		$236K Buy
+100
New +$22.7K 0.06% 127

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arthur M. Cohen & Associates's AMED Position: Q3 2021 in Review

Arthur M. Cohen & Associates sold out of Amedisys (AMED) in Q3 2021, closing a stake of 1,000 shares — an estimated $245K sold.

Arthur M. Cohen & Associates first reported a position in AMED in Q3 2020 and held it in 4 quarters. The position peaked at $293K in Q4 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Arthur M. Cohen & Associates reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Arthur M. Cohen & Associates sold 1,000 Amedisys shares in Q3 2021, an estimated $245K.
  • Arthur M. Cohen & Associates first reported a position in Amedisys in Q3 2020 and held it in 4 quarters.
  • Arthur M. Cohen & Associates's Amedisys position peaked at $293K in Q4 2020.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Arthur M. Cohen & Associates's 13F filing for Q3 2021, filed 8 Oct 2021.